{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06004063",
            "orgStudyIdInfo": {
                "id": "2021-0116"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2023-06448",
                    "type": "OTHER",
                    "domain": "NCI-CTRP Clinical Trials Registry"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Paranteral Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Randomized Controlled Study",
            "officialTitle": "Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Paranteral Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Randomized Controlled Study",
            "therapeuticArea": [
                "Other"
            ],
            "study": "safety-tolerability-and-efficacy-of-enteral-nutrition-versus-paranteral-nutrition-in-hematopoietic-stem-cell-transplant-patients-a-pilot-randomized-controlled-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-08-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-15",
            "studyFirstSubmitQcDate": "2023-08-15",
            "studyFirstPostDateStruct": {
                "date": "2023-08-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-18",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-20",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this research study is to learn if feeding someone after a stem cell transplant is safe and practical.",
            "detailedDescription": "Primary Objective:\n\na. To determine feasibility of administering enteral nutrition (EN) via NG/GT in SCT population in peri-transplant period.\n\nSecondary Objectives:\n\n1. Determine the differential effects of enteral feeding versus Parenteral feeding on nutrition, and quality of life.\n2. Determine the differential effects of enteral feeding versus parenteral feeding on survival and, medical comorbidities\n3. Determine the differential effects of enteral feeding versus parenteral feeding on Fitbit data study for patients co-enrolled in Pediatric Energy Balance Data Repository Protocol PA18-0130.\n4. Identify differential effects on microbiome for patients co-enrolled on \"A Study to Collect Peripheral Blood, Tissue, and Bone Marrow samples from Donors and Recipients of blood and marrow transplants for Laboratory Research Protocol Lab99-062\".\n5. Determine adverse effects of enteral feeding in this population"
        },
        "conditionsModule": {
            "conditions": [
                "Stem Cell"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Enteral nutrition (EN)-Group 1",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive enteral feeding (directly into the stomach) based on your ability to receive your daily caloric needs by mouth. Participants will be monitored by a dietician and may receive feeding by vein to achieve caloric goals.",
                    "interventionNames": [
                        "Dietary Supplement: Enteral nutrition (EN)",
                        "Other: Standard care parenteral nutrition (PN)"
                    ]
                },
                {
                    "label": "Standard care parenteral nutrition (PN)-Group 2",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants will receive the standard of care. Participants will be monitored by a dietician to see if the participants are able to receive your daily caloric needs by mouth. Some participants may be able to receive oral dietary supplements, but if this is not possible or not enough, participants will begin receiving standard of care feeding by vein.",
                    "interventionNames": [
                        "Other: Standard care parenteral nutrition (PN)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Enteral nutrition (EN)",
                    "description": "Given by Nasogastric Tube",
                    "armGroupLabels": [
                        "Enteral nutrition (EN)-Group 1"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Standard care parenteral nutrition (PN)",
                    "description": "Given by PO or Given by IV (vein)",
                    "armGroupLabels": [
                        "Enteral nutrition (EN)-Group 1",
                        "Standard care parenteral nutrition (PN)-Group 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0",
                    "timeFrame": "through study completion; an average of 1 year."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Be admitted to an inpatient pediatric or adult ward for the purpose of HSCT.\n2. Be greater than 2 years of age and less than 25 years of age at time of study enrollment.\n3. Participants \\> 18 or guardians for participants \\< 18 are willing and able to give written informed consent and to comply with all of the study activities. Assent is required for children \\> 7 years old.\n4. Participants will be encouraged to co-enroll on two additional related energy -balance protocols (highly encouraged but not required)\n5. Participants will be asked to consider co-enrollment on Stem Cell Registry studies (not required):\n\nExclusion Criteria:\n\n1. Patients in whom EN is contraindicated (e.g intestinal ischemia, complete bowel obstruction, or other anatomical obstructive process), or all available routes of EN are contraindicated. Surgical GT placements for the sole purpose of study participation will not be entertained.\n2. Females who are pregnant. We follow FACT guidelines. Per Foundation for the Accreditation of Cellular Therapy (FACT), female patients must have a negative pregnancy test 7 days prior to bone marrow transplant. .",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Shehla Razvi, MD",
                    "role": "CONTACT",
                    "phone": "(713) 792-6635",
                    "email": "srazvi@mdanderson.org"
                },
                {
                    "name": "Karen Moody, MD",
                    "role": "CONTACT",
                    "phone": "713-792-6610",
                    "email": "kmoody@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Shehla Razvi, MD",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "M D Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Shehla Razvi, MD",
                            "role": "CONTACT",
                            "phone": "713-792-6635",
                            "email": "srazvi@mdanderson.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "M D Anderson Cancer Center",
                    "url": "http://www.mdanderson.org"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}